Diseases, Conditions, Syndromes

Doctor details two new hepatitis C drugs

In the last three weeks, the Food and Drug Administration has approved two new drugs that are expected to dramatically improve treatment of chronic hepatitis C, a liver-damaging viral infection that afflicts more than 3.2 ...

Diseases, Conditions, Syndromes

Getting personal with hep B vaccines

Therapeutic vaccines that boost antiviral immunity provide an attractive alternative to drug therapy for people who are infected with the hepatitis B virus (HBV). Yet, the large amount of genetic diversity found in circulating ...

Diseases, Conditions, Syndromes

FDA approves new treatment for hepatitis C infection

(HealthDay)—The U.S. Food and Drug Administration has approved a new drug for chronic hepatitis C infection that some experts hope will cut down on side effects from current therapies.

Diseases, Conditions, Syndromes

Vaccination campaign doubles HBV mutations

A universal infant vaccination campaign in China has led the Hepatitis B virus (HBV) to more than double its rate of "breakout" mutations. These mutations may enable the virus to elude the vaccine, necessitating new vaccination ...

Medical research

New mouse model for hepatitis C

Hepatitis C affects about three million people in the U.S. and is a leading cause of chronic liver disease, so creating a vaccine and new treatments is an important public health goal. Most research to date has been done ...

page 39 from 40